Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China
· Delayed Price · Currency is CNY 17.92
-0.06 (-0.33%)
Mar 11, 2026, 2:14 PM CST
SHA:603079 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,365 | 2,281 | 2,486 | 2,148 | 2,962 | 3,698 | Upgrade
|
| Market Cap Growth | 42.16% | -8.28% | 15.73% | -27.46% | -19.91% | -17.09% | Upgrade
|
| Enterprise Value | 3,117 | 2,298 | 2,343 | 1,896 | 2,598 | 3,323 | Upgrade
|
| Last Close Price | 17.98 | 13.47 | 14.49 | 12.42 | 16.92 | 20.72 | Upgrade
|
| PE Ratio | 53.38 | 77.51 | - | 68.24 | 39.09 | 18.73 | Upgrade
|
| Forward PE | - | 55.60 | 55.60 | 55.60 | 55.60 | 55.60 | Upgrade
|
| PS Ratio | 4.01 | 2.76 | 3.42 | 2.91 | 3.75 | 4.26 | Upgrade
|
| PB Ratio | 2.10 | 1.78 | 1.96 | 1.60 | 2.22 | 2.79 | Upgrade
|
| P/TBV Ratio | 2.51 | 2.23 | 2.46 | 1.96 | 2.57 | 3.28 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 14.91 | Upgrade
|
| P/OCF Ratio | 25.06 | 15.42 | 38.60 | 52.76 | 39.77 | 11.10 | Upgrade
|
| EV/Sales Ratio | 3.71 | 2.78 | 3.22 | 2.57 | 3.29 | 3.83 | Upgrade
|
| EV/EBITDA Ratio | 20.93 | 21.83 | 133.26 | 32.90 | 19.77 | 10.03 | Upgrade
|
| EV/EBIT Ratio | 42.66 | 72.85 | - | - | 42.95 | 12.70 | Upgrade
|
| EV/FCF Ratio | -300.74 | - | - | - | - | 13.40 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.21 | 0.19 | 0.03 | 0.13 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 2.06 | 2.48 | 13.19 | 0.73 | 1.28 | 0.37 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.49 | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.06 | -0.07 | -0.21 | -0.27 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.87 | -0.78 | -4.98 | -5.00 | -2.78 | -1.36 | Upgrade
|
| Net Debt / FCF Ratio | 26.71 | 3.75 | 0.48 | 12.78 | 14.35 | -1.81 | Upgrade
|
| Asset Turnover | 0.43 | 0.47 | 0.43 | 0.43 | 0.46 | 0.54 | Upgrade
|
| Inventory Turnover | 3.19 | 3.12 | 2.51 | 2.44 | 2.94 | 2.41 | Upgrade
|
| Quick Ratio | 3.39 | 1.94 | 1.51 | 1.58 | 1.62 | 1.92 | Upgrade
|
| Current Ratio | 4.41 | 2.82 | 2.35 | 2.64 | 2.23 | 2.46 | Upgrade
|
| Return on Equity (ROE) | 4.76% | 2.92% | -4.15% | 2.27% | 5.40% | 16.99% | Upgrade
|
| Return on Assets (ROA) | 2.35% | 1.13% | -2.02% | -0.37% | 2.18% | 10.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.33% | 2.01% | -4.87% | -0.83% | 5.88% | 25.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 2.10% | -3.80% | -0.70% | 4.50% | 19.50% | Upgrade
|
| Earnings Yield | 1.82% | 1.29% | -2.17% | 1.47% | 2.56% | 5.34% | Upgrade
|
| FCF Yield | -0.31% | -0.96% | -7.30% | -1.05% | -0.86% | 6.71% | Upgrade
|
| Dividend Yield | - | - | 0.41% | 0.48% | 0.83% | 1.69% | Upgrade
|
| Payout Ratio | 12.21% | 61.41% | - | 87.12% | 86.42% | 9.53% | Upgrade
|
| Buyback Yield / Dilution | -16.46% | -2.45% | 3.41% | -1.59% | -2.03% | -7.64% | Upgrade
|
| Total Shareholder Return | -16.46% | -2.45% | 3.82% | -1.11% | -1.20% | -5.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.